tbuckley/cabot-search huggingface dataset:
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression
Authors: Matthew B. Wall, Lysia Demetriou, Bruna Giribaldi, Leor Roseman, Natalie Ertl, David Erritzoe, David J. Nutt, Robin L. Carhart-Harris
Journal: American Journal of Psychiatry (2025)

Psilocybin is an emerging intervention for depression that may be at least as effective as selective serotonin reuptake inhibitors (SSRIs), but effects of the two treatments on the neural correlates of emotional processing have never been directly compared. The authors assessed neural responses to emotional faces using blood-oxygen-level-dependent (BOLD) functional MRI (fMRI) in two groups with major depression. One group (N=25; 9 women and 16 men) received two dosing sessions with 25 mg psilocybin plus 6 weeks of daily inert placebo, and the second group (N=21; 6 women and 15 men) received 6 weeks of escitalopram plus two dosing sessions with a nonpsychoactive (placebo) dose of 1 mg psilocybin. Both groups had equal psychological support throughout: 3 hours of preparation, one in-person integration session following the psilocybin dosing sessions, and two further integration sessions conducted via video call or telephone. An emotional face fMRI paradigm was completed before treatment and at the 6-week posttreatment primary end point (3 weeks following psilocybin dosing sessions). Patient group (psilocybin versus escitalopram) interacted with time point (before versus after treatment) on a distributed set of cortical regions. Post hoc within-condition analyses showed that posttreatment BOLD responses to emotional faces of all types were significantly reduced in the escitalopram group, with no change or a slight increase in the psilocybin group. Analyses of amygdala responsivity showed a reduction of response to fearful faces in the escitalopram group, but lesser effects for the psilocybin group. Despite large improvements in depressive symptoms in the psilocybin group, psilocybin therapy had only a minor effect on brain responsiveness to emotional stimuli. These results are consistent with prior findings that the antidepressant action of SSRIs is often accompanied by a reduction in emotional responsiveness, but this effect may not occur in psychedelic therapy.
Relationship Between Problematic Alcohol Use and Various Psychiatric Disorders: A Genetically Informed Study
Authors: Yeeun Ahn, Jaehyun Kim, Kyeongmin Jung, Dong June Lee, Jin Young Jung, Yewon Eom, Sanghyeon Park, Jaeyoung Kim, Hyejin Kim, Hyeonbin Jo, Sanghoon Hong, Kevin S. O’Connell, Ole A. Andreassen, Woojae Myung, Hong-Hee Won
Journal: American Journal of Psychiatry (2025)

Problematic alcohol use (PAU) adversely affects the clinical course of psychiatric disorders. Genetic studies have suggested that genetic factors underlie the co-occurrence of PAU with psychiatric disorders. This study aimed to elucidate shared genetic architectures, prioritizing genes that disorders may have in common. Using genome-wide association data of PAU including 435,563 samples from people of European ancestry, this study investigated the genetic relationship between PAU and 11 psychiatric disorders using a bivariate causal mixture model (MiXeR). Local genetic correlation and colocalization analyses were conducted to identify the genomic regions significantly associated with PAU and each psychiatric disorder. Postanalysis included the false discovery rate (FDR) and transcriptome-wide association studies (TWASs), as well as summary-data-based Mendelian randomization to prioritize shared genes by integrating brain transcriptome data. MiXeR analysis revealed a substantial polygenic overlap (39%-73%) between PAU and psychiatric disorders. Four bivariate genomic regions with high correlations suggest shared causal variants of PAU with major depression and schizophrenia. Within these regions, four and six genes for the PAU-major depression and PAU-schizophrenia pairs, respectively, were mapped by conjunctional FDR analysis. Furthermore, TTC12 and ANKK1 were identified as potential causal genes for PAU and these disorders. The findings were replicated in multi-ancestry analyses of colocalization and TWASs. Despite the varying degrees of genetic overlap and directions of shared genetic effect correlations, these results imply the presence of shared genetic factors influencing the comorbidity of PAU and psychiatric disorders. Additionally, TTC12 and ANKK1, located near DRD2, may be causally associated with comorbid conditions.
Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood
Authors: Sarah Whittle, Divyangana Rakesh, Julian G. Simmons, Orli Schwartz, Nandita Vijayakumar, Nicholas B. Allen
Journal: American Journal of Psychiatry (2025)

Brain structural alterations are consistently reported in depressive disorders, yet it remains unclear whether these alterations exist prior to disorder onset and thus may reflect a preexisting vulnerability. The authors investigated prospective adolescent neurodevelopmental risk markers for depressive disorder onset, using data from a 15-year longitudinal study. A community sample of 161 adolescents participated in neuroimaging assessments conducted during early (age 12), mid (age 16), and late (age 19) adolescence. Onsets of depressive disorders were assessed for the period spanning early adolescence through emerging adulthood (ages 12-27). Forty-six participants (28 female) experienced a first episode of a depressive disorder during the follow-up period; 83 participants (36 female) received no mental disorder diagnosis. Joint modeling was used to investigate whether brain structure (subcortical volume, cortical thickness, and surface area) or age-related changes in brain structure were associated with the risk of depressive disorder onset. Age-related increases in amygdala volume (hazard ratio=3.01), and more positive age-related changes (i.e., greater thickening or attenuated thinning) of temporal (parahippocampal gyrus, hazard ratio=3.73; fusiform gyrus, hazard ratio=4.14), insula (hazard ratio=4.49), and occipital (lingual gyrus, hazard ratio=4.19) regions were statistically significantly associated with the onset of depressive disorder. Relative increases in amygdala volume and temporal, insula, and occipital cortical thickness across adolescence may reflect disturbances in brain development, contributing to depression onset. This raises the possibility that prior findings of reduced gray matter in clinically depressed individuals instead reflect alterations that are caused by disorder-related factors after onset.
Advancing an Inflammatory Subtype of Major Depression
Authors: Andrew H. Miller
Journal: American Journal of Psychiatry (2025)

Chronic inflammation plays a prominent role in multiple medical disorders, including psychiatric diseases such as major depression. Exposure to inflammatory stimuli leads to changes in neurotransmitter systems and neurocircuits in the brain that are associated with depressive symptoms. Blockade of inflammatory cytokines can reduce depressive symptoms in medically ill and medically healthy individuals with depression. Increased levels of biomarkers of inflammation are associated with an overrepresentation of neurovegetative symptoms, including anhedonia, fatigue, and psychomotor slowing, and can predict response to antidepressant treatments. Importantly, however, increased inflammatory biomarkers occur in only a subgroup of individuals with depression. Thus, there appears to be a subset of patients with depression with a unique symptom presentation and treatment response whose disease is primarily driven by inflammation. Further identifying and characterizing this inflammatory subtype of depression can foster the development of treatments targeting the immune system and its effects on the brain. Moreover, by using this mechanism-based approach to parsing the heterogeneity of depression, we can refine our diagnostic nosology and model a strategy for precision medicine and targeted therapeutics in psychiatry.
FRI-509 Assessing the safety and efficacy of advanced therapies to treat inflammatory bowel disease in patients with a liver transplant
Authors: Samantha Campbell, Andrzej Rak, Alexandra Frolkis, Chandni Radia, Mehul Patel, Polychronis Pavlidis, Miriam Cortes Cerisuelo, Abdul Hakeem, Jeremy Nayagam, Alexandra Kent, Deepak Joshi
Journal: Journal of Hepatology (2025)
THU-312 Clinical outcomes of primary sclerosing cholangitis associated with inflammatory bowel disease after liver transplantation: a systematic review and meta-analysis
Authors: Jiangrong Zhou, Dennis Sneek, Bettina E. Hansen, Caroline den Hoed, Marin de Jong, Qiuwei Pan, Adriaan J. van der Meer, Pengfei Li, Annemarie de Vries
Journal: Journal of Hepatology (2025)
THU-279 One-year efficacy and safety of tacrolimus in chronic autoimmune hepatitis
Authors: Alessio Gerussi, Armando Curto, Eugenia Nofit, Davide Bernasconi, Alessandra Bonfichi, Daphne D’Amato, Olga Falco, Miki Scaravaglio, Federica Malinverno, Laura Cristoferi, Marco Carbone, Pietro Invernizzi
Journal: Journal of Hepatology (2025)
FRI-327-YI Genetic ablation of interleukin 17A augments fibrosis in a mouse model of cholestatic liver injury
Authors: Takashi Kitagataya, Anuradha Krishnan, Kirsta E. Olson, Adiba Azad, Florencia Gutierrez, Michelle Baez-Faria, Maria Eugenia Guicciardi, Ana Sofia Garcia Moreno, Kevi D. Pavelko, Goki Suda, Naoya Sakamoto, Gregory Gores
Journal: Journal of Hepatology (2025)
THU-293 Disparities in treatment response and liver decompensation by race and ethnicity in primary biliary cholangitis: results from the ELLA-PBC cohort
Authors: Paul Yoon, Adriana Shen, Matthew Chen, Tara Foroohar, Isai Martinez Rios, Sade Brown, Kali Zhou, Jeffrey Kahn, Brian Lee, Jennifer Dodge, Lily Dara
Journal: Journal of Hepatology (2025)
FRI-319 Dnmt1 deletion impairs liver regeneration and stem cell activation during cholestatic liver disease
Authors: Juliana Marques Affonso, Jovana Castven, Lina Jegodzinski, Carolin Zimpel, Martha M. Kirstein, Diana Becker, Benjamin Heckelmann, Rüdiger Braun, Darko Castven, Jens U. Marquardt
Journal: Journal of Hepatology (2025)
THU-315 Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-life setting
Authors: Johannes Wiegand, Annegret Franke, Tobias Müller, Kerstin Stein, Heike Bantel, Rainer Guenther, Gerald Denk, Philipp Reuken, Jörn M. Schattenberg, Uwe Naumann, Tobias Böttler, Andreas Weber, Stefan Zeuzem, Matthias Hinz, Robin Greinert, Christoph P. Berg, Th. Till Wissniowski, Karl-Georg Simon, Jonel Trebicka, Rüdiger Behrens, Wolf Peter Hofmann, Nektarios Dikopoulos, Christoph Sarrazin, Elke Roeb, Andreas E. Kremer, Marion Muche, Marc Ringelhan, Andreas Teufel, Uta Merle, Verena Keitel-Anselmino, Jens U. Marquardt, Achim Kautz, Katja Piotrowski, Nicole Köppe-Bauernfeind, Christian Trautwein, Thomas Berg
Journal: Journal of Hepatology (2025)
THU-288 Prognostic value of liver stiffness dynamics in patients with autoimmune hepatitis
Authors: Lukas Burghart, Sonja Treiber, David Bauer, Georg Semmler, Emina Halilbasic, Benedikt Hofer, Mattias Mandorfer, Michael Gschwantler, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer
Journal: Journal of Hepatology (2025)
THU-326 Epidemiological and clinical differences in primary sclerosing cholangitis between men and women in Spain: a multicenter analysis of 697 patients
Authors: Arantxa Caballero, Sergio Rodriguez-Tajes, Ana Arencibia Almeida, Elena Gómez-Domínguez, Cristina Montón, Agustín Castiella, Javier Martínez González, Maria Luisa Gonzalez Dieguez, Isabel Conde, Nerea Quintans, Nicolau Vallejo Senra, Mar Riveiro Barciela, Vanesa Lucía Ortega Quevedo, Gema De la Cruz, María Del Barrio, Maria Trapero, Angela Martínez Herreros, Jesús M. González-Santiago, Judith Gómez-Camarero, Vanesa Bernal, Sonia Blanco-Sampascual, Patricia Camacho, Inmaculada Castello, Carolina Almohalla Alvarez, Margarita Sala Llinás, Maria José Blanco, Montserrat Garcia-Retortillo, Sara Lorente Perez, Manuel Delgado, Joaquín Míquel, Jorge Torrente Sánchez, Alexia Maria Fernandez Lopez, Maria Angeles Lopez Garrido, Diana Horta, Indhira Perez Medrano, María Pilar Rios, Mariano Gómez-Rubio, Belen Piqueras Alcol, Merce Roget Alemany, Roberto Paton, Miguel Fernandez-Bermejo, Raquel Ríos León, Laura Castillo-Molina, Janire Prieto, Rosa M Morillas, Maria Luisa Gutiérrez, Francisco Javier Bustamante Schneider, Helena Hernández Evole, Ainhoa Fernández-Yunquera, Sheyla Correa Torres, Ares Villagrasa, Álvaro Díaz-González, Ismael El Hajra Martínez, Samuel Fernández-Prada, Trinidad Serrano, María Carlota Londoño, Conrado Fernandez-Rodriguez, Magdalena Salcedo
Journal: Journal of Hepatology (2025)
FRI-310 Quantitative MRI metrics in the liver and pancreas for disease assessment in IgG4-related sclerosing cholangitis with autoimmune pancreatitis
Authors: Edward Jackson, Michele Pansini, George Ralli, Yameng Deng, Alexandre Triay Bagur, Seliat Olodo-Atitebi, Adam Bailey, Emmanuel Selvaraj, Michael Pavlides, Emma Culver
Journal: Journal of Hepatology (2025)
SAT-057 Time-restricted feeding modulates genes involved in liver regeneration and damage regression processes in a rat model treated with diethylnitrosamine
Authors: Christian Molina-Aguilar, Felipe Castañeda, Fernanda Guadalupe Arriaga-González, Julieta Berenice Rivera-Zavala, Melany Vivanco Valenzuela, Martín del Castillo Velasco-Herrera, Kenya Contreras, Valeria Martínez Cuevas, David J. Adams, Mauricio Díaz-Muñoz, Carla Daniela Robles-Espinoza
Journal: Journal of Hepatology (2025)
THU-305 Quantitative morphometric analysis via artificial intelligence- driven image analysis in autoimmune hepatitis: a multi-center study
Authors: Giorgio Cazzaniga, Elisa Merelli, Bastian Engel, Francesca Bolis, Alberto Marini, Eugenia Nofit, Laura Cristoferi, Davide Bernasconi, Federica Malinverno, Raffaella Viganò, Richard Taubert, Gaia Chiarello, Mario Livio Pietro Camozzi, Fabio Pagni, Marco Carbone, Pietro Invernizzi, Alessio Gerussi
Journal: Journal of Hepatology (2025)
SAT-058-YI MAIT cells mediate liver tissue repair via VEGF and VIM secretion
Authors: Katia Sayaf, Hossain Delowar Akther, Martin J. Lett, Aneesha Bhandari, Lucy C. Garner, Narayan Ramamurthy, Carl-Philipp Hackstein, Francesco Paolo Russo, Paul Klenerman
Journal: Journal of Hepatology (2025)
FRI-322-YI A combined immunotherapy that maintains the balance and stability of intrahepatic regulatory T cells to enhance biliary regeneration
Authors: Man Chun Wong, Naruhiro Kimura, Gareth Hardisty, Ben Higgins, Pei-Chi Huang, Maxym Besh, Tim Kendall, Adriano Rossi, Prakash Ramachandran, Daniel Patten, Graham Anderson, Shishir Shetty, David Withers, Atsunori Tsuchiya, Shuji Terai, Wei-Yu Lu
Journal: Journal of Hepatology (2025)
THU-292 Serum levels of IL-31 and autotaxin are independently associated with pruritus severity in patients with primary sclerosing cholangitis
Authors: Cynthia Levy, Daniel Pratt, Craig Lammert, Stuart C. Gordon, Michael Li, Lisa Forman, Richard Dean, Maryam Yazdanfar, Isha Patel, Raghav Bordia, Duru Cosar, Katherine Specht, Fawzy Barry, Megan McLaughlin, Sumanta Mukherjee, Usha Gungabissoon, Christopher L. Bowlus
Journal: Journal of Hepatology (2025)
THU-301 Fibrates in primary sclerosing cholangitis: a multicenter retrospective observational study
Authors: Laura Cristoferi, Eugenia Nofit, Mariko Maxwell, Louisa Lund, Rodrigo Motta, Armando Curto, Davide Bernasconi, Daphne D’Amato, Alessio Gerussi, Pietro Invernizzi, James L. Boyer, Emma Culver, Christoph Schramm, David N. Assis, Marco Carbone
Journal: Journal of Hepatology (2025)
THU-327 Rituximab therapy for autoimmune hepatitis cirrhosis is associated with a high rate of complete biochemical response and improvement in MELD score
Authors: Mar Riveiro-Barciela, Lourdes Ruiz, Stella Gabeta, Diego Rincón, Yooyun Chung, Rosa Rota, Indhira Perez Medrano, Elena Gómez-Domínguez, Javier Ampuero Herrojo, Juan Carlos Ruiz-Cobo, Jesús M González, Edouard Bardoy-Jacques, Rodrigo Liberal, María Carlota Londoño, Magdalena Salcedo, Michael Heneghan, George Dalekos
Journal: Journal of Hepatology (2025)
THU-320 Diagnostic distribution of patients positive for anti- mitochondrial antibodies (subtype), anti-sp100, and anti-gp210: pathological examination is necessary of PBC diagnosis: a retrospective study based on liver biopsy
Authors: Hongli Liu, Xing Liu, Yi-Fan Hu, Sha-Sha Li, Xi-Xuan Wang, Yi-Jun Bao, Yu Zhang, Li Wang, Zhi-Xiang Du, Miao-Yang Chen, Qing-Fang Xiong, Yan-Dan Zhong, Cai-Yun Zhang, Du-Xian Liu, Ping Huang, Wen-Quan Zeng, Min Ai, Kai Zhang, Yongfeng Yang
Journal: Journal of Hepatology (2025)
FRI-476 Current status of endoscopic treatment for anastomotic biliary stricture after living donor liver transplantation at our institution
Authors: EIsuke Ozawa, Akane Shimakura, Naohiro Komatsu, Mizuki Kitagawa, Yasuhiko Nakao, Kousuke Takahashi, Ryu Sasaki, Masafumi Haraguchi, Masanori Fukushima, Satoshi Miuma, Hisamitsu Miyaaki
Journal: Journal of Hepatology (2025)
THU-285 Prognostic factors in autoimmune hepatitis: a french multicenter study
Authors: Anna Sessa, Edouard Bardou-Jacquet, Antonio Saviano, Lorraine Blaise, Marianne Ziol, Nathalie Ganne-Carrié, Stefano Caruso, Pierre Allaume, Julien Calderaro, Vincent Leroy
Journal: Journal of Hepatology (2025)
FRI-313 Epstein-Barr virus is targeted by converging T and B cell responses in primary sclerosing cholangitis
Authors: Hesham ElAbd, Mitchell Pesesky, Gabriel Innocenti, Brian K. Chung, Aya Mahdy, Valeriia Kriukova, Laila Kulsvehagen, Dennis Strobbe, Claudia Stühler, Gabriele Mayr, Damon May, Melanie Prinzensteiner, Tim Steiert, Florian Tran, Michel V. Hadjihannas, Rainer Günther, Elisa Rosati, Sören Mucha, Wolfgang Lieb, Malte Ziemann, Astrid Dempfle, Felix Braun, Trine Folseraas, Johannes R. Hov, Espen Melum, Petra Bacher, Martina Sterneck, Tobias Weismüller, Henrike Lenzen, Bernd Bokemeyer, Bryan Howie, Harlan Robins, Christoph Röcken, Stefan Schreiber, Nina Khanna, Anne-Katrin Pröbstel, Christoph Schramm, Thomas Vogl, Tom Hemming Karlsen, Andre Franke
Journal: Journal of Hepatology (2025)
THU-280-YI Efficacy, safety and long-term clinical outcomes of a low-dose versus high-dose prednisolone induction in autoimmune hepatitis: a propensity score matched analysis
Authors: Arnav Aggarwal, Shekhar Swaroop, Sagnik Biswas, Shubham Mehta, Sarthak Saxena, Rajkumar Bayye, Umang Arora, Ayush Agarwal, Samagra Agarwal, Deepak Gunjan, Baibaswata Nayak, Shalimar Shalimar
Journal: Journal of Hepatology (2025)
FRI-314-YI Mitochondrial dynamics and auto(mito)phagy are altered in experimental models of primary biliary cholangitis, contributing to disease pathogenesis
Authors: Irune Lasa-Elosegi, Laura Izquierdo-Sánchez, Paula Olaizola, Ainhoa Lapitz, Mireia Tena-Garitaonaindia, Santiago Iturbe-Rey, Beatriz Val, Maite G. Fernandez-Barrena, Luis Bujanda, Maria Jesus Perugorria, Pedro Rodrigues, Jesus Maria Banales
Journal: Journal of Hepatology (2025)
THU-323 A larger decline of IgG after initiation of treatment in patients with AIH is associated with complete biochemical response despite having normal baseline IgG levels
Authors: Lorenz Grossar, Sarah Raevens, Anja Geerts, Christophe van Steenkiste, Isabelle Colle, Charlotte de Vloo, Hans Orlent, Jeoffrey Schouten, Marie Gallant, Annelien van Driessche, Hans van Vlierberghe, Xavier Verhelst
Journal: Journal of Hepatology (2025)
THU-302 Impact of social determinants of health on outcome of autoimmune liver diseases: insights from the european reference network on hepatological diseases (ERN RARE-LIVER)
Authors: Franziska Stallbaum, Carmen Auhuber, Irina Adao, Nora Cazzagon, George Dalekos, Friederike Dellbrügge, Joost P.H. Drenth, Alessio Gerussi, Tom J.G. Gevers, Maciej Janik, Melvin Kuiper, Angela Leburgue, María Carlota Londoño, Mirjam Kolev, Joao Madaleno, Eirini Rigopoulou, Piotr Milkiewicz, Sergio Rodriguez-Tajes, Nasser Semmo, José Willemse, Martine Walmsley, Henriette Ytting, Christoph Schramm, Ansgar W. Lohse, Michele Tana, Marcial Sebode
Journal: Journal of Hepatology (2025)
FRI-320-YI Single-cell profiling reveals increased IGHG2+ memory and activated IGHA1+ intrahepatic B cells in primary sclerosing cholangitis
Authors: Lisa R.V. Brynjulfsen, Markus S. Jördens, Jonas Øgaard, Amber Bozward, Tom Hemming Karlsen, Ye Htun Oo, Espen Melum, Brian K. Chung
Journal: Journal of Hepatology (2025)
THU-321 Real-world assessment of standard of care trends in primary biliary cholangitis and cholestatic pruritus in Europe
Authors: Kaitlin Hagan, Lina Titievsky, Atif Adam, James Brash, Petter Egger, Frank Tacke, Christophe Corpechot, Marco Carbone, Alexander Cobitz, Anna Halliday, Megan McLaughlin
Journal: Journal of Hepatology (2025)
THU-340 Validation of the clinical global impression severity scale for primary biliary cholangitis: a clinical trials outcome tool
Authors: Nasir Hussain, Rachel Smith, Sarah Barnum, Nadir Abbas, Sarah Al Shakhshir, Geraldine Carroll, Laura Jopson, Jessica Leighton, George Mells, Mo Christie, Robert Mitchell-Thain, Aaron Wetten, Jessica Dyson, James Neuberger, Magnus Doverskog, Palak J. Trivedi, Judith Jaeger, David Jones
Journal: Journal of Hepatology (2025)
THU-309-YI Liver steatosis prevalence in primary sclerosing cholangitis
Authors: Imante Lasyte, Johannes R. Hov, Lina Lindström, Michael Ingre, Fredrik Rorsman, Nils Nyhlin, Antonio Molinaro, Stergios Kechagias, Annika Bergquist
Journal: Journal of Hepatology (2025)
THU-272 Appraising improvement in prediction of clinical outcomes based on different response criteria and liver stiffness measurements in patients with primary biliary cholangitis treated with second-line therapies
Authors: Antonio de Vincentis, Francesca Terracciani, Daphne D’Amato, Laura Cristoferi, Alessio Gerussi, Pietro Invernizzi, Miki Scaravaglio, Ester Vanni, Daniela Campion, Anna Morgando, Vincenzo Valiani, Vincenzo Boccaccio, Filomena Morisco, Lorenzo Surace, Ilaria Cavalli, Guido Delle Monache, Federico Salomone, Donatella Ieluzzi, Debora Angrisani, Biagio Cuffari, Alessandra Moretti, Gerardo Nardone, Mauro Viganò, Stefano Fagiuoli, Giovanni Vettori, Federica Cerini, Giancarlo Gimignani, Alberto Mattalia, Fabrizio Pizzolante, Nicoletta de Matthaeis, Cristina Rigamonti, Giulia Francesca Manfredi, Valentina Boano, Paola Begini, Ana Lleo, Francesca Colapietro, Riccardo Plebani, Domenico Alvaro, Rosanna Venere, Marta Borghi, Elisabetta Degasperi, Pietro Lampertico, Sara Labanca, Edoardo Giovanni Giannini, Raffaella Viganò, Federico D’Amico, Antonino Castellaneta, Francesco Squeo, Luca Cadamuro, Marco Marzioni, Guido Poggi, Alessandro Mussetto, Raffaele Cozzolongo, Francesco Losito, Gaetano Bertino, Maurizio Russello, Maria Rita Cannavò, Paolo Scivetti, Maurizio Pompili, Annalisa Tortora, Grazia Anna Niro, Rosa Cotugno, Pietro Pozzoni, Luchino Chessa, Michela Miglianti, Giuseppe Cuccorese, Valeria Pace Palitti, Ludovico Abenavoli, Natalia Terreni, Teresa Zolfino, Olivia Morelli, Carlo Saitta, Silvia Casella, Adriano Pellicelli, Maurizia Brunetto, Barbara Coco, Andrea Galli, Fabio Marra, Armando Curto, Annarosa Floreani, Nora Cazzagon, Paolo Rollo, Emanuela Bonaiuto, Loredana Simone, Luigi Muratori, Floriano Rosina, Marco Distefano, Elisa Capello, Valentina Bellia, Rodolfo Sacco, Giuliano Alagna, Leonardo Baiocchi, Saveria Lory Crocé, Chiara Ricci, Paolo Poisa, Antonio Izzi, Sara Boninsegna, Vincenza Calvaruso, Marco Carbone, Umberto Vespasiani-Gentilucci
Journal: Journal of Hepatology (2025)
FRI-058-YI Time-resolved liver fibrosis regression at single-cell resolution in a murine CCl4-cessation model
Authors: Katharina Bonitz, Thomas Sorz-Nechay, Henriette Horstmeier, Vlad Taru, Oleksandr Petrenko, Benedikt Hofer, Benedikt Simbrunner, Kerstin Zinober, Hubert Scharnagl, Michael Trauner, Stefan Günther Kauschke, Peng Sun, Eric Simon, Philipp Schwabl, Thomas Reiberger
Journal: Journal of Hepatology (2025)
THU-336-YI Direct nerve fiber recordings reveal functional alterations in cutaneous C-fibers linked to itch severity in cholestatic liver diseases
Authors: Miriam M. Düll, Hannah Kleinlein, Fabienne Falter, Anne Bauer, Markus F. Neurath, Sonja Ständer, Aysenur Süer, Martin Schmelz, Peter Dietrich, Andreas E. Kremer, Barbara Namer
Journal: Journal of Hepatology (2025)